SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    575.00 (12.92%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £334.70m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

21 Mar 2011 07:00

RNS Number : 2707D
Judges Scientific PLC
21 March 2011
 

JUDGES SCIENTIFIC plc

("Judges Scientific", "Judges" or the "Company")

 

ACQUISITION OF 51% OF DEBEN UK LIMITED

 

Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, announces that it completed on 18 March the acquisition of a 51% indirect interest in Deben UK Limited ("Deben") for a cash consideration of £3.26 million (the "Acquisition").

 

An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Such payment is expected by Judges to be covered by the cash inherited on completion.

 

The Acquisition has been executed through Bordeaux Acquisition Limited ("BAL"), a 51% owned subsidiary of Judges, which was created for the purpose of effecting the acquisition and which acquired the entirety of Deben's share capital.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed through a £2,422,250 loan provided by Lloyds Bank Corporate Markets to BAL. The loan is split into two parts, both guaranteed by Judges, and comprises an acquisition component of £2.06 million and a property element of £362,250, secured against the freehold property from which Deben operates its business.

 

Equity of £1,013,250 was supplied by the BAL shareholders, pro-rata to their respective interests, predominantly in the form of subordinated loans. Gary and Tracey Edwards, the vendors of Deben, have reinvested £497,000 of their sale proceeds to acquire a 49% shareholding in BAL, while Judges invested £516,250 in respect of its 51% interest.

 

Both parties have entered into a Shareholders' Agreement which includes minority protection provisions and stipulates, inter alia, that BAL has the right of first refusal on potential acquisitions available to the Judges group, provided that such acquisitions meet certain criteria, operate in the field of electron microscopy and can be financed independently by BAL.

 

Information on Deben

Deben designs, manufactures and sells devices used to enable or improve the observation of objects under a microscope. The principal product groups are motor control systems, micro-tensile stages, cooling stages, digital imaging for electron microscopes and beam blanking equipment. The products are sold world-wide to OEM customers (microscope manufacturers that incorporate such equipment in their own instruments) or directly to end users such as universities.

 

The business, established in 1987, is based in Woolpit, Suffolk, and has been managed by Gary Edwards since 1996. It is expected that Mr Edwards, 44, will continue as managing director of Deben for the foreseeable future.

 

Deben's unaudited accounts for the year ended 31 October 2010 show sales of £2 million and pre-tax profits of £862,000. Operating profits, adjusted to eliminate non-recurring items and to reflect Judges Scientific's practices, would have amounted to £707,000. The accounts show net tangible assets of £2.25 million including net cash of £1.36 million. The freehold property was valued on BAL's behalf at £517,500. The price paid for Deben reflects this valuation as well as a multiple of adjusted operating profit.

 

The Board believes that this acquisition is an excellent addition to the Group's electron microscopy business and will be immediately earnings enhancing.

 

Alex Hambro, Chairman of Judges, commented:

"We are delighted to be able to expand our electron microscopy business through the acquisition of Deben. This is a profitable and cash generative business and we expect the transaction, which has not involved the issue of new equity, to be immediately earnings enhancing. We welcome Gary and his team into the Judges group for what we anticipate will be a long and fruitful relationship ".

 

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital: Tel: 020 7408 4090

 

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

Websites:

 Judges Scientific:www.judges.uk.com

 

Deben: www.deben.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURSSRAKAOUAR
Date   Source Headline
29th Jul 20093:53 pmRNSShare buyback programme
29th Jul 20099:45 amRNSDirector/PDMR Shareholding
28th Jul 20099:55 amRNSHolding(s) in Company
27th Jul 20097:00 amRNSDirector/PDMR Shareholding
24th Jul 20098:38 amRNSDirector/PDMR Shareholding
20th Jul 20097:00 amRNSTrading Statement
2nd Jul 20095:30 pmRNSHolding(s) in Company
18th Jun 200912:54 pmRNSFurther re Acquisition
10th Jun 20097:00 amRNSAcquisition
22nd May 20093:13 pmRNSAGM Statement
30th Apr 20091:54 pmRNSAnnual Financial Report
30th Mar 20097:00 amRNSFinal Results
30th Jan 20099:04 amRNSShare buyback programme
21st Jan 20097:00 amRNSTrading Statement
17th Dec 20082:46 pmRNSDirectorate Change
17th Nov 20087:00 amRNSAcquisition activity
26th Aug 20087:00 amRNSInterim Results
22nd Aug 200810:50 amRNSNotice of Results
15th Jul 20087:00 amRNSTrading Statement
13th Jun 20084:51 pmRNSHolding(s) in Company
13th Jun 20084:25 pmRNSHolding(s) in Company
13th Jun 20083:16 pmRNSHolding(s) in Company
9th Jun 20084:22 pmRNSFurther re Issue of Equity
22nd May 20087:00 amRNSAGM Statement
21st May 20087:00 amRNSIssue of Equity
29th Apr 20087:01 amRNSDirector/PDMR Shareholding
28th Apr 20085:28 pmRNSCirc re. Panel Waiver
28th Mar 20087:01 amRNSFinal Results
25th Mar 20087:01 amRNSFreehold property purchase
29th Jan 20087:00 amRNSPre Close Trading Statement
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
27th Nov 20077:01 amRNSDirector/PDMR Shareholding
4th Oct 20077:01 amRNSDirector/PDMR Shareholding
25th Sep 20071:25 pmRNSGrant of Options/Dir holding
21st Sep 20077:02 amRNSInterim Results
9th Aug 20074:31 pmRNSHolding in Poole Investments
2nd Aug 20074:33 pmRNSCompany Website
21st May 20075:54 pmRNSResult of AGM
23rd Mar 20077:01 amRNSPreliminary Results
16th Mar 20077:00 amRNSNotice of Preliminary Results
9th Jan 20077:00 amRNSTrading Statement
21st Dec 20061:49 pmRNSTotal Voting Rights
7th Nov 20063:12 pmBUSRule 8.3 - Corus Group PLC
27th Oct 20062:29 pmBUSRule 8.3 - Corus Group PLC
26th Sep 20067:03 amRNSInterim Results
22nd Sep 20067:00 amRNSNotice of Results
5th Sep 20067:02 amRNSAcquisition
28th Mar 200612:31 pmRNSDirector/PDMR Shareholding
21st Mar 20067:01 amRNSFinal Results
21st Mar 20067:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.